Downregulation of long noncoding RNA HCP5 contributes to cisplatin resistance in human triple-negative breast cancer via regulation of PTEN expression

Published 2019 View Full Article

Authors

Keywords

HCP5, Cisplatin resistance, Triple-Negative breast cancer, PTEN

Journal

BIOMEDICINE & PHARMACOTHERAPY

Volume 115, Issue -, Pages 108869

Publisher

Elsevier BV

Online

2019-04-24

DOI

10.1016/j.biopha.2019.108869

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started